| Dr Vlad Andrei Radulescu, MD | |
|
1500 E 2nd St Ste 400, Reno, NV 89502 | |
| (775) 982-2400 | |
| (775) 982-2410 |
| Full Name | Dr Vlad Andrei Radulescu |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 11 Years |
| Location | 1500 E 2nd St Ste 400, Reno, Nevada |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1538402987 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 18626 (Nevada) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Renown Regional Medical Center | Reno, NV | Hospital |
| Renown South Meadows Medical Center | Reno, NV | Hospital |
| Carson Valley Medical Center | Gardnerville, NV | Hospital |
| Banner Churchill Community Hospital | Fallon, NV | Hospital |
| Banner Lassen Medical Center | Susanville, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Community Care Services Llc | 1951324318 | 385 |
| Community Care Services Llc | 1951324318 | 385 |
| Northern Inyo Healthcare District | 8921992090 | 86 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
"In an era of strained finances, it makes sense to invest in solutions that save money in the long run. HIV vaccine development fits that bill. As we mark the 30th anniversary of AIDS, there could be no better way to commemorate the occasion than to renew our commitment to its end".
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Among older women residing in nursing homes, administration of cranberry capsules compared with placebo resulted in no significant difference in presence of bacteriuria plus pyuria (presence of bacteria and white blood cells in the urine, a sign of urinary tract infection [UTI]), or in the number of episodes of UTIs over l year, according to a study published online by JAMA.
› Verified 3 days ago
| Entity Name | Community Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720031768 PECOS PAC ID: 1951324318 Enrollment ID: O20060111000900 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
"In an era of strained finances, it makes sense to invest in solutions that save money in the long run. HIV vaccine development fits that bill. As we mark the 30th anniversary of AIDS, there could be no better way to commemorate the occasion than to renew our commitment to its end".
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Among older women residing in nursing homes, administration of cranberry capsules compared with placebo resulted in no significant difference in presence of bacteriuria plus pyuria (presence of bacteria and white blood cells in the urine, a sign of urinary tract infection [UTI]), or in the number of episodes of UTIs over l year, according to a study published online by JAMA.
› Verified 3 days ago
| Entity Name | Washoe Barton Medical Clinic A Nevada Nonprofit Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1396799102 PECOS PAC ID: 7214835149 Enrollment ID: O20061127000164 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
"In an era of strained finances, it makes sense to invest in solutions that save money in the long run. HIV vaccine development fits that bill. As we mark the 30th anniversary of AIDS, there could be no better way to commemorate the occasion than to renew our commitment to its end".
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Among older women residing in nursing homes, administration of cranberry capsules compared with placebo resulted in no significant difference in presence of bacteriuria plus pyuria (presence of bacteria and white blood cells in the urine, a sign of urinary tract infection [UTI]), or in the number of episodes of UTIs over l year, according to a study published online by JAMA.
› Verified 3 days ago
| Entity Name | Community Care Services Llc |
|---|---|
| Entity Type | Part B Supplier - Intensive Cardiac Rehabilitation |
| Entity Identifiers | NPI Number: 1295180735 PECOS PAC ID: 1951324318 Enrollment ID: O20170111001838 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
"In an era of strained finances, it makes sense to invest in solutions that save money in the long run. HIV vaccine development fits that bill. As we mark the 30th anniversary of AIDS, there could be no better way to commemorate the occasion than to renew our commitment to its end".
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Among older women residing in nursing homes, administration of cranberry capsules compared with placebo resulted in no significant difference in presence of bacteriuria plus pyuria (presence of bacteria and white blood cells in the urine, a sign of urinary tract infection [UTI]), or in the number of episodes of UTIs over l year, according to a study published online by JAMA.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Vlad Andrei Radulescu, MD 1155 Mill St # Mcm14, Reno, NV 89502-1576 Ph: (775) 982-5262 | Dr Vlad Andrei Radulescu, MD 1500 E 2nd St Ste 400, Reno, NV 89502 Ph: (775) 982-2400 |
News Archive
OncoGenex Pharmaceuticals, Inc. today announced plans for the initiation of the Cedar clinical trial, an investigator-sponsored, randomized, open-label Phase 2 trial evaluating OGX-427 in previously untreated patients with advanced squamous cell lung cancer.
"In an era of strained finances, it makes sense to invest in solutions that save money in the long run. HIV vaccine development fits that bill. As we mark the 30th anniversary of AIDS, there could be no better way to commemorate the occasion than to renew our commitment to its end".
Bioengineering researchers at University of California, Santa Barbara have found that changing the shape of chemotherapy drug nanoparticles from spherical to rod-shaped made them up to 10,000 times more effective at specifically targeting and delivering anti-cancer drugs to breast cancer cells.
Among older women residing in nursing homes, administration of cranberry capsules compared with placebo resulted in no significant difference in presence of bacteriuria plus pyuria (presence of bacteria and white blood cells in the urine, a sign of urinary tract infection [UTI]), or in the number of episodes of UTIs over l year, according to a study published online by JAMA.
› Verified 3 days ago
Dr. Richard Bruce Rosen, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 781 Mill St, Reno, NV 89502 Phone: 775-398-1980 Fax: 775-398-1981 | |
Rahul Navin Mediwala, Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1500 E 2nd St, Suite 201, Reno, NV 89502 Phone: 775-982-3355 Fax: 775-982-3356 | |
Dr. Raymond Hill Scott Iii, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 330 Crampton St, Reno, NV 89502 Phone: 775-336-3700 Fax: 775-336-3701 | |
Dr. Bruce William Denney, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1155 Mill St Ms W14, Reno, NV 89502 Phone: 775-982-7878 Fax: 775-982-4196 | |
Dr. Elmer Epres Alegre, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1715 Kuenzli St, Reno, NV 89502 Phone: 775-329-5162 Fax: 775-334-4356 | |
Dr. Devang Mahesh Desai, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 645 N Arlington Ave Ste 555, Reno, NV 89503 Phone: 775-770-7622 Fax: 775-770-3683 | |
Dr. Louis Christopher Tripoli, M.D. Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1510 Meadow Wood Ln, Prominence Health, Reno, NV 89502 Phone: 775-770-9242 Fax: 928-832-2864 |